Analytical Data
-
基因名
IL-2R beta/CD122
-
简介
IL-2R beta (CD122), a type Ⅰ cytokine receptor expressed on T lymphocytes, is a receptor for IL-2 (Kd: 1 nM approximately)[1]. IL-2R beta mediates T cell immune responses, such as stimulating T cell proliferation and activating lymphokine-activated killer cells[2]. IL-2R beta/CD122 Protein, Rhesus Macaque (HEK293, Fc) is a recombinant Rhesus Macaque IL-2R beta with a C-Terminal hFc tag, which is produced in HEK293 cells.
- Application
-
别名
Interleukin-2 receptor subunit beta; IL2RB; High affinity IL-2 receptor subunit beta; CD122
-
种属
Rhesus Macaque
-
表达系统
HEK293
-
标签
C-hFc
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
NP_001244989.1
-
表达区间
A27-D239
-
蛋白长度
Partial
-
分子量
51.4 kDa.
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Interleukin-2 receptor beta (IL-2Rβ/CD122) is a crucial component of the IL-2 receptor complex, which plays an essential role in the modulation of immune responses. This receptor is primarily expressed on activated T cells and natural killer (NK) cells and is involved in mediating the effects of interleukin-2 (IL-2), a key cytokine for T cell proliferation, differentiation, and survival. Research into IL-2Rβ/CD122 has gained prominence due to its implications in various immunological disorders, including autoimmune diseases, cancer, and infections. The receptor exists in different forms, including a high-affinity complex with IL-2Rα (CD25) and a lower-affinity form in conjunction with the common gamma chain (CD132). This diversity allows for fine-tuning of immune responses, making it a target for therapeutic interventions. Recombinant forms of IL-2Rβ/CD122 have been produced for both functional studies and potential clinical applications, including the development of novel immunotherapies. Understanding the structure and function of this receptor is essential for designing effective treatments that enhance immune responses or mitigate excessive inflammation. Thus, the continued exploration of IL-2Rβ/CD122 as a therapeutic target holds promise for advancing strategies to manipulate the immune system in various diseases.
